Updates are available Correction dated 2022-07-04
Click to view Correction: https://doi.org/10.1038/s42003-022-03612-5
-
Authors
Bianco, Gaia
Coto-Llerena, Mairene
Gallon, John http://orcid.org/0000-0002-5328-6298
Kancherla, Venkatesh
Taha-Mehlitz, Stephanie
Marinucci, Mattia http://orcid.org/0000-0002-8546-5231
Konantz, Martina http://orcid.org/0000-0002-4319-3119
Srivatsa, Sumana http://orcid.org/0000-0002-2471-8821
Montazeri, Hesam
Panebianco, Federica
Tirunagaru, Vijaya G.
De Menna, Marta
Paradiso, Viola
Ercan, Caner http://orcid.org/0000-0002-5611-2699
Dahmani, Ahmed
Montaudon, Elodie
Beerenwinkel, Niko http://orcid.org/0000-0002-0573-6119
Kruithof-de Julio, Marianna http://orcid.org/0000-0002-6085-7706
Terracciano, Luigi M.
Lengerke, Claudia http://orcid.org/0000-0001-5442-2805
Jeselsohn, Rinath M. http://orcid.org/0000-0001-7996-7529
Doebele, Robert C. http://orcid.org/0000-0001-6728-6857
Bidard, François-Clément http://orcid.org/0000-0001-5932-8949
Marangoni, Elisabetta http://orcid.org/0000-0002-3337-6448
Ng, Charlotte K. Y. http://orcid.org/0000-0002-6100-0026
Piscuoglio, Salvatore http://orcid.org/0000-0003-2686-2939
- License Information
-
More Information
Article History
Received: 7 January 2021
Accepted: 18 March 2022
First Online: 19 April 2022
Change Date: 4 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s42003-022-03612-5
Competing interests
: The authors declare the following competing interests: part of this study has been submitted for a patent application (applicants: the University of Basel and ETH Zürich; the name of the inventors: G.B., S.S., H.M., N.B., C.K.Y.N., and S.P. The patent application has been submitted to the European patent office; application number: EP19216550.4). V.T. and R.C.D. are employed at Rain Therapeutics Inc. G.B. is employed at Novartis NIBR; however, she worked on the manuscript when still affiliated with the University of Basel. R.J. received research funding from Pfizer and Lilly and is a consultant for Luminex. The other authors declare no competing interests.
